Sharland, Alexandra <br/><br/>
Genetically modified HLA class I molecules able to inhibit human NK cells without provoking alloreactive CD8+ CTLs.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Apr 2002 
 - 3266-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.168.7.3266  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aspartic Acid--genetics<br/>Cell Death--genetics<br/>Cell Line<br/>Cell Line, Transformed--immunology<br/>Clone Cells<br/>Cytotoxicity Tests, Immunologic<br/>Cytotoxicity, Immunologic--genetics<br/>Dose-Response Relationship, Immunologic<br/>Down-Regulation--genetics<br/>Genetic Vectors--immunology<br/>HLA-C Antigens--biosynthesis<br/>Humans<br/>Immunophenotyping<br/>Killer Cells, Natural--immunology<br/>Lymphocyte Activation--genetics<br/>Lymphocyte Subsets--immunology<br/>Lysine--genetics<br/>Mutagenesis, Site-Directed<br/>Receptors, Immunologic--metabolism<br/>Receptors, KIR<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Transfection